Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas.
Aberrant activation of MAP kinase signaling pathway and loss of tumor suppressor LKB1 have been implicated in lung cancer development and progression. Although oncogenic KRAS mutations are frequent, BRAF mutations (BRAF(V600E)) are found in 3% of human non-small cell lung cancers. Contrary to KRAS m...
Guardado en:
Autores principales: | Elena González-Sánchez, Juan Martín-Caballero, Juana María Flores, Javier Hernández-Losa, Ma Ángeles Montero, Javier Cortés, Roso Mares, Mariano Barbacid, Juan A Recio |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9678441d61b544159212b4cfb22eb5a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
por: Shujing Liu, et al.
Publicado: (2018) -
Author Correction: Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
por: Shujing Liu, et al.
Publicado: (2019) -
Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
por: Zaharie F, et al.
Publicado: (2015) -
Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.
por: Jieun Koh, et al.
Publicado: (2013) -
The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors.
por: Ashwin A Dihal, et al.
Publicado: (2013)